Ingrid Choong

2.9k total citations
20 papers, 1.5k citations indexed

About

Ingrid Choong is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Ingrid Choong has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Ingrid Choong's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Chemical Synthesis and Analysis (4 papers). Ingrid Choong is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Chemical Synthesis and Analysis (4 papers). Ingrid Choong collaborates with scholars based in United States, Türkiye and France. Ingrid Choong's co-authors include Jonathan A. Ellman, Dustin J. Maly, W. Michael Flanagan, Jeffrey S. Glenn, Stephan Miller, Johan D. Oslob, John Eldredge, Eric S. Day, Annemarie Stroustrup and Amy Fung and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Ingrid Choong

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Choong United States 12 646 357 318 200 164 20 1.5k
Lawrence J. Wilson United States 24 743 1.2× 309 0.9× 717 2.3× 65 0.3× 153 0.9× 59 1.6k
N.O. Concha United States 17 1.2k 1.9× 179 0.5× 164 0.5× 135 0.7× 118 0.7× 23 2.0k
Tove Tuntland United States 25 732 1.1× 151 0.4× 482 1.5× 126 0.6× 131 0.8× 39 1.7k
Yew Mun Lee Singapore 20 825 1.3× 164 0.5× 237 0.7× 211 1.1× 93 0.6× 33 1.7k
Rao Sethumadhavan India 23 1.3k 1.9× 111 0.3× 136 0.4× 205 1.0× 98 0.6× 88 1.8k
Francesco Saverio Di Leva Italy 28 1.0k 1.6× 306 0.9× 365 1.1× 219 1.1× 134 0.8× 67 1.8k
Youcef Mehellou United Kingdom 20 1.1k 1.6× 567 1.6× 485 1.5× 38 0.2× 116 0.7× 40 1.9k
Shenping Liu United States 21 1.2k 1.8× 165 0.5× 351 1.1× 98 0.5× 184 1.1× 39 2.1k
Shridhar Bhat United States 21 1.5k 2.4× 333 0.9× 403 1.3× 71 0.4× 203 1.2× 37 2.6k
David P. Jacobus United States 20 396 0.6× 319 0.9× 360 1.1× 207 1.0× 43 0.3× 59 1.3k

Countries citing papers authored by Ingrid Choong

Since Specialization
Citations

This map shows the geographic impact of Ingrid Choong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Choong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Choong more than expected).

Fields of papers citing papers by Ingrid Choong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Choong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Choong. The network helps show where Ingrid Choong may publish in the future.

Co-authorship network of co-authors of Ingrid Choong

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Choong. A scholar is included among the top collaborators of Ingrid Choong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Choong. Ingrid Choong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Etzion, Ohad, Saeed Hamid, Yoav Lurie, et al.. (2023). Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial. Hepatology. 77(6). 2093–2103. 27 indexed citations
2.
Cardozo-Ojeda, E. Fabián, Saeed Hamid, Yoav Lurie, et al.. (2022). Mathematical modeling of HDV RNA kinetics suggests high peginterferon Lambda efficacy in blocking viral production: insights from the LIMT-1 study. Journal of Hepatology. 77. S859–S859. 2 indexed citations
3.
Dinnon, Kenneth H., Sarah R. Leist, Alexandra Schäfer, et al.. (2021). Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 590(7844). E22–E22. 7 indexed citations
4.
Yurdaydın, Cihan, Onur Keskın, Aysun Çalışkan, et al.. (2021). A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis. Hepatology. 75(6). 1551–1565. 50 indexed citations
5.
Dinnon, Kenneth H., Sarah R. Leist, Alexandra Schäfer, et al.. (2020). A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 586(7830). 560–566. 381 indexed citations
6.
Wang, Yan, Jeffrey S. Glenn, Mark A. Winters, et al.. (2018). A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection. Diagnostic Microbiology and Infectious Disease. 92(2). 112–117. 7 indexed citations
7.
Yurdaydın, Cihan, Çağdaş Kalkan, Ersin Karataylı, et al.. (2016). Hepatitis Delta Virus Kinetics under the Prenylation Inhibitor Lonafarnib Suggest HDV-Mediated Suppression of HBV Replication. Journal of Hepatology. 64(2). S587–S587. 4 indexed citations
8.
Yurdaydın, Cihan, Ramazan Idılman, Ingrid Choong, et al.. (2015). O118 : Optimizing the prenylation inhibitor lonafarnib using ritonavir boosting in patients with chronic delta hepatitis. Journal of Hepatology. 62. S252–S252. 11 indexed citations
9.
10.
Ameriks, Michael K., Scott D. Bembenek, Matthew Burdett, et al.. (2010). Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(14). 4060–4064. 16 indexed citations
11.
Choong, Ingrid, Iana M. Serafimova, David E. Stockett, et al.. (2008). A diaminocyclohexyl analog of SNS-032 with improved permeability and bioavailability properties. Bioorganic & Medicinal Chemistry Letters. 18(21). 5763–5765. 10 indexed citations
12.
Fahr, Bruce J., David E. Stockett, Sravanthi Cheeti, et al.. (2008). Modifications of the isonipecotic acid fragment of SNS-032: Analogs with improved permeability and lower efflux ratio. Bioorganic & Medicinal Chemistry Letters. 18(23). 6236–6239. 5 indexed citations
13.
Fucini, Raymond V., Emily J. Hanan, M.J. Romanowski, et al.. (2008). Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5648–5652. 30 indexed citations
14.
He, Molly M., Annemarie Stroustrup, Johan D. Oslob, et al.. (2005). Small-Molecule Inhibition of TNF-α. Science. 310(5750). 1022–1025. 457 indexed citations
15.
Erlanson, Daniel A., Joni W. Lam, Christian Wiesmann, et al.. (2003). In situ assembly of enzyme inhibitors using extended tethering. Nature Biotechnology. 21(3). 308–314. 155 indexed citations
16.
Allen, Darin A., Ingrid Choong, Bruce J. Fahr, et al.. (2003). Identification of potent and novel small-Molecule inhibitors of caspase-3. Bioorganic & Medicinal Chemistry Letters. 13(21). 3651–3655. 18 indexed citations
17.
Choong, Ingrid, Willard Lew, Dennis Lee, et al.. (2002). Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design. Journal of Medicinal Chemistry. 45(23). 5005–5022. 83 indexed citations
18.
Maly, Dustin J., Ingrid Choong, & Jonathan A. Ellman. (2000). Combinatorial target-guided ligand assembly: Identification of potent subtype-selective c-Src inhibitors. Proceedings of the National Academy of Sciences. 97(6). 2419–2424. 144 indexed citations
19.
Choong, Ingrid & Jonathan A. Ellman. (1999). Synthesis of Alkoxylamines by Alkoxide Amination with 3,3‘-Di-tert-butyloxaziridine. The Journal of Organic Chemistry. 64(18). 6528–6529. 47 indexed citations
20.
Choong, Ingrid & Jonathan A. Ellman. (1997). ChemInform Abstract: Solid‐Phase Synthesis: Applications to Combinatorial Libraries. ChemInform. 28(14). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence J. Wilson Breakdown of academic impact, for papers by N.O. Concha Breakdown of academic impact, for papers by Tove Tuntland Breakdown of academic impact, for papers by Yew Mun Lee Breakdown of academic impact, for papers by Rao Sethumadhavan Breakdown of academic impact, for papers by Francesco Saverio Di Leva Breakdown of academic impact, for papers by Youcef Mehellou Breakdown of academic impact, for papers by Shenping Liu Breakdown of academic impact, for papers by Shridhar Bhat Breakdown of academic impact, for papers by David P. Jacobus
Rankless by CCL
2026